Lindbrook Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $129K | Buy |
1,882
+142
| +8% | +$9.7K | 0.01% | 571 |
|
|
2024
Q4 | $135K | Buy |
1,740
+1,239
| +247% | +$96.4K | 0.01% | 475 |
|
|
2024
Q3 | $33.6K | Sell |
501
-1,213
| -71% | -$81.3K | ﹤0.01% | 1011 |
|
|
2024
Q2 | $194K | Sell |
1,714
-41
| -2% | -$4.65K | 0.02% | 370 |
|
|
2024
Q1 | $243K | Buy |
1,755
+172
| +11% | +$23.9K | 0.02% | 318 |
|
|
2023
Q4 | $196K | Buy |
1,583
+268
| +20% | +$33.3K | 0.02% | 351 |
|
|
2023
Q3 | $123K | Sell |
1,315
-264
| -17% | -$24.6K | 0.01% | 415 |
|
|
2023
Q2 | $203K | Buy |
1,579
+1
| +0.1% | +$129 | 0.02% | 322 |
|
|
2023
Q1 | $183K | Buy |
1,578
+107
| +7% | +$12.4K | 0.02% | 333 |
|
|
2022
Q4 | $167K | Buy |
1,471
+422
| +40% | +$47.8K | 0.02% | 370 |
|
|
2022
Q3 | $84K | Buy |
1,049
+295
| +39% | +$23.6K | 0.01% | 489 |
|
|
2022
Q2 | $56K | Buy |
754
+38
| +5% | +$2.82K | 0.01% | 615 |
|
|
2022
Q1 | $92K | Sell |
716
-28
| -4% | -$3.6K | 0.01% | 492 |
|
|
2021
Q4 | $100K | Buy |
744
+252
| +51% | +$33.9K | 0.02% | 491 |
|
|
2021
Q3 | $67K | Buy |
492
+28
| +6% | +$3.81K | 0.02% | 361 |
|
|
2021
Q2 | $50K | Sell |
464
-44
| -9% | -$4.74K | 0.01% | 477 |
|
|
2021
Q1 | $46K | Buy |
508
+68
| +15% | +$6.16K | 0.01% | 478 |
|
|
2020
Q4 | $41K | Sell |
440
-136
| -24% | -$12.7K | 0.01% | 460 |
|
|
2020
Q3 | $59K | Buy |
576
+112
| +24% | +$11.5K | 0.02% | 314 |
|
|
2020
Q2 | $47K | Sell |
464
-72
| -13% | -$7.29K | 0.01% | 368 |
|
|
2020
Q1 | $36K | Buy |
536
+160
| +43% | +$10.7K | 0.01% | 396 |
|
|
2019
Q4 | $21K | Buy |
376
+76
| +25% | +$4.25K | 0.01% | 721 |
|
|
2019
Q3 | $11K | Hold |
300
| – | – | ﹤0.01% | 867 |
|
|
2019
Q2 | $11K | Sell |
300
-40
| -12% | -$1.47K | ﹤0.01% | 859 |
|
|
2019
Q1 | $10K | Buy |
340
+40
| +13% | +$1.18K | ﹤0.01% | 888 |
|
|
2018
Q4 | $8K | Buy |
+300
| New | +$8K | ﹤0.01% | 871 |
|